Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Finasteride improves chronic pelvic pain, saw palmetto doesn't.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Hair mineral analysis might help diagnose diseases early, but standard methods are needed.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.